The 2026 Medical Pharmacy Trend Report: Part 1– Payer Survey reflects Prime Therapeutics’ long standing commitment to delivering trusted, data driven perspectives that shape the industry conversation. Drawing on input from executives representing 246 million covered lives, the annual payer survey report explores emerging strategies in gene therapy, oncology, biosimilars, artificial intelligence, and integrated specialty management—revealing where plans are investing, where barriers persist, and what will influence decision making in the years ahead. 

Our medical pharmacy and data analysis experts gather and translate real world payer feedback into thought leadership that helps inform and influence our clients’ decision making and reinforces our role as a respected voice in medical pharmacy management. For timely updates, we’re publishing the findings in three parts this year; the full Medical Pharmacy Trend Report is scheduled for publication in this fall and will include and build on earlier results with comprehensive medical benefit drug trends and forecasts.
 

• Read the report